top
Search terms
Results 1 - 10 of 419 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 42
Escardio

The third aspect is that some treatment for comorbidities may exacerbate the patient’s heart failure. “The best example, and the most frequent in clinical practice, is the use of ...

Date : 22/05/2016
Escardio

The announcement comes as the long-term phase of the cardiomyopathy registry is started and the study on heart failure patients conducted in collaboration with the Organisation for Economic ...

Date : 30/08/2014
Escardio

In the phase IIB study, serelaxin was safe and well tolerated, with positive clinical outcome symptoms and signals in patients with acute heart failure. There was, however, an improvement in ...

Date : 28/04/2017
Escardio

“A lot more attention needs to be paid to CSA in heart failure,” said presenter of the study Professor Piotr Ponikowski, from the Medical University, 4th Military Hospital (Wroclaw, ...

Date : 31/05/2010
Escardio

Most of the studies behind these claims, however, are considering the effect of coffee in the primary prevention (or risk) of heart disease; less well explored is the association between coffee and ...

Date : 07/05/2010
Escardio

Congestive heart failure affects millions of individuals worldwide, and the prevalence is rising, primarily due to an ageing population.1 Several classes of drug are currently being considered as ...

Date : 28/05/2018
Escardio

Cardiology is becoming interdisciplinary, bringing different fields together, and a heart failure doctor in any department of cardiology plays a key role in connecting all of the other ...

Date : 01/05/2017
Escardio

The enormous costs of mortality and hospitalisation among patients with decompensated chronic heart failure needs to be faced head-on to avoid spiralling healthcare costs, delegates will be warned ...

Date : 24/05/2016
Escardio

Paradigm-HF trial in heart failure Cecilia Linde from the Karolinska Institute in Sweden proposed that the Paradigm-HF study makes a strong case that the angiotensin receptor inhibitor/neprilysin ...

Date : 30/08/2015
Escardio

What did you do after this degree? I started to work as a postdoc in Prof. Mauro Giacca’s laboratory at the International Centre for Genetic Engineering and Biotechnology (ICGEB, Trieste ...

Date : 27/06/2018